Veterinary Vaccines Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Veterinary Vaccines Market by Product type (Live Stock Vaccines (Bovine Vaccines, Poultry Vaccines, Small Ruminants Vaccines), Companion Animal Vaccine (Canine Vaccines, Feline Vaccines), Porcine Vaccines, Equine Vaccines, Others), disease type (Live Stock Diseases (Foot and Mouth Diseases, Brucellosis, Infectious Bronchitis, Marek’s Disease, Newcastle Disease, Others), Companion Animal Diseases(Canine Distemper, Canine Parvovirus, Feline Rabies, Others) Equine Diseases, Porcine Diseases, Aquaculture Diseases, vaccine type(Live Attenuated Vaccines, Inactivated Vaccines, Recombinant vaccines, Toxoid vaccines, Conjugate Vaccines, DNA Vaccines, Subunit Vaccines), distribution channel ( Veterinary Pharmacies, Veterinary Hospitals, Veterinary Clinics, E-Commerce) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Veterinary Vaccines market size was valued at USD 7.8 billion in 2021 and poised to grow US$ 12.86 Billion at a CAGR of 7.4% by 2027 during the forecast period 2021-2027. owing to rising immunization programmes in animals and increasing stakeholder involvement to contain the disease in animals. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market. In addition, the report includes animal demographics; regulatory scenario, top meat-producing countries, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the market report include suppliers, manufacturers, marketers, policymakers, and veterinary healthcare service providers engaged in manufacturing and supply of veterinary vaccines products.


Veterinary Vaccines Market

MARKET SUMMARY
-
7.4% CAGR
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– 7.4%
  • Largest Market– Europe
  • Fastest Growing Market– North America

Veterinary Vaccines Market Analysis

  • Animals illnesses are adding issues inside livestock production systems. These problems include productivity losses, uncertain food security, and loss of income, among others, which are adversely affecting human health.
  • Animals infection the board can lessen sickness through the immunization of creatures. Foot-and-mouth sickness (FMD) is exceptionally infectious among cloven-hoofed creatures, similar to dairy cattle, pigs, sheep, and goats, just as numerous types of wild creatures.
  • Players in the veterinary vaccine market are launching the products in newer markets to garner larger market share in the market. For instance in 2015, Boehringer Ingelheim animal health launched two new vaccines in Europe market which offer sustainable control of Porcine Reproductive and Respiratory Syndrome (PRRS) in pigs
Market Leaders
  • Bayer AG (Germany)
  • Boehringer Ingelheim GmbH (Germany)
  • Ceva Santé Animale (France)
  • Eli Lilly and Company (U.S)
  • Hester Biosciences (India)
  • Merck & Co., Inc. (U.S)
  • Vétoquinol S.A. (France)
  • Virbac S.A. (France)
  • Zoetis Inc. (U.S)
Veterinary Vaccines Market

Drivers and Restraints

The rise in demand for safe and effective meat for consumption and rising trade restriction of meat and animal owing to zoonotic diseases expected to create demand for veterinary vaccines over the forecast period. For instance, Global Rinderpest Eradication Program aims at vaccination, trade restrictions, and surveillance of rinderpest in animals. Moreover, market growth is driven by improving food security and rising human and pet bondage adoption in recent times.The growth of veterinary Vaccines market expected to hinder over forecast period owing to lack of cold chain infrastructure for vaccine storage and transportation in several developing and underdeveloped economies. Moreover, the dearth of diseases surveillance data for carving out effective immunization programs expected to impede veterinary vaccine market growth over the forecast period.


Veterinary Vaccines Market Regional Analysis

Europe dominates the market

Europe accounted for larger revenue share in global veterinary vaccines market with moderate CAGR. There has been increased in awareness among cattlemen in U.S. regarding animal rearing, animal health and proper vaccination and judicious use of antibiotics in animals, which are driving the market revenue growth in the region. Asia Pacific market projected to grow at significant rate owing large pool of animal population and increased consumption and trade of meat.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2015-2020) and forecast (2021-2027)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Veterinary Vaccines Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

  1. Research Methodology
  • Secondary and Primary research
    • Secondary Sources
    • Primary Sources
  • Market Revenue Estimation Methodology
  • Key Assumptions
  • Acronyms
  1. Scope of Study
    • Market Definition
    • Objective of the Research
    • Regions covered in the study
  2. Executive summary
  3. Global Veterinary Vaccines Market Dynamic Factors
    • Drivers
      • Economic Drivers
      • Demand Side Drivers
      • Supply Side Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
  4. Unique Features of the Report
    • Competition analysis
      • Dash board of top players
      • Financial Analysis
      • Product & Services
      • Key Developments
      • Major Strategies
      • SWOT Analysis
    • Technological advancements in veterinary vaccines market
    • Recent investments in the industry
    • Regulatory landscape
      • Europe
    • PESTLE analysis
    • Porter’s analysis
  5. Global Veterinary Vaccines Market, By Product, 2013 – 2017 and Forecast, 2018 – 2024
    • Live Stock Vaccines
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
      • Bovine Vaccine
        • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%)
      • Poultry Vaccines
        • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%)
      • Small Ruminants Vaccine
        • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%)
      • Companion Animal Vaccine
        • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%)
        • Canine Vaccines
          • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%)
        • Feline Vaccines
          • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%)
        • Porcine Vaccines
          • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%)
        • Equine Vaccines
          • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%)
        • Others
          • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%)
  1. Global Veterinary Vaccines Market Forecast, By Disease, 2013 – 2017 and Forecast, 2018 – 2024
    • Live Stock Diseases
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
      • Foot and Mouth Disease
      • Brucellosis
        • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%)
      • Infectious Bronchitis
        • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%)
      • Marek’s Disease
        • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%)
      • Newcastle Disease
        • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%)
      • Others
        • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%)
      • Companion Animal Diseases
        • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%)
        • Canine Distemper
          • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%)
        • Canine Parvovirus
          • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%)
        • Feline Rabies
          • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%)
        • Others
          • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%)
        • Equine Diseases
          • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%)
        • Porcine Diseases
          • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%)
        • Aquaculture Diseases
          • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%)
  1. Global Veterinary Vaccines Market Forecast, By Vaccine Type, 2013 – 2017 and Forecast, 2018 – 2024
    • Live Attenuated Vaccines
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Inactivated Vaccines
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Recombinant Vaccines
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Toxoid Vaccines
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Conjugate Vaccines
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • DNA Vaccines
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Subunit Vaccines
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
  1. Global Veterinary Vaccines Market Forecast, By Distribution Channel, 2013 – 2017 and Forecast, 2018 – 2024
    • Veterinary Hospitals
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Veterinary Clinics
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Others
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024(Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)

Report

Company Profile

  • Bayer AG (Germany)
  • Boehringer Ingelheim GmbH (Germany)
  • Ceva Santé Animale (France)
  • Eli Lilly and Company (U.S)
  • Hester biosciences (India)
  • Merck & Co., Inc. (U.S)
  • Vétoquinol S.A. (France)
  • Virbac S.A. (France)
  • Zoetis Inc. (U.S)

Description

Veterinary Vaccines market size was valued at USD 7.8 billion in 2021 and poised to grow US$ 12.86 Billion at a CAGR of 7.4% by 2027 during the forecast period 2021-2027. owing to rising immunization programmes in animals and increasing stakeholder involvement to contain the disease in animals. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market. In addition, the report includes animal demographics; regulatory scenario, top meat-producing countries, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the market report include suppliers, manufacturers, marketers, policymakers, and veterinary healthcare service providers engaged in manufacturing and supply of veterinary vaccines products.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX